The pharmacological profile of GHK-Cu observed in preclinical models covers a broad spectrum of activity: Stimulation of extracellular matrix synthesis influence on the production of collagen, elastin and glycosaminoglycans in dermal fibroblasts Pro-regenerative and pro-angiogenic effects in in vivo and in vitro wound healing models Modulation of gene expression in transcriptomic studies, the impact on hundreds of tissue repair and antioxidant defense genes Transport of copper ions GHK as a physiological carrier of Cu, a cofactor of matrix enzymes Antioxidant and anti-inflammatory activity reduction of oxidative stress markers in cell models GHK-Cu is a model ligand for testing in the group of plasma peptides connective tissue remodeling and copper biology combines a signaling function with trace element transport, making it a tool for studying the interface between copper metabolism and extracellular matrix repair
Recent studies of peptide-bound, active, Gs-coupled, structures of CTR or AMYRs provide evidence supporting distinct conformations of receptors when bound to CT peptides versus amylin peptides 15 that may contribute to pharmacological differences between dual CTR and AMYR agonists
This dual mechanism is one reason peptide therapy is being explored more aggressively in men who do not respond adequately to first-line treatments
The morning protocol Wake up
Chronic stress keeps your body in a state of constant alert, never allowing your muscles to fully relax or stress hormones to return to baseline levels
On a 0.5 ml syringe, major markers sit at 5, 10, 15, 20, 25, 30, 35, 40, 45, and 50
